The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's ...

INDIANAPOLIS, May 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to ...

Eli Lilly and Company announced the launch of Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL [U-200]). Eli Lilly and Company announced the launch of Humalog 200 units/mL KwikPen (insulin ...

The Food and Drug Administration (FDA) has approved Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL [U-200]; Eli Lilly) to improve glycemic control in patients with type 1 and type 2 ...

The FINANCIAL — Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL; U-200), the first and only concentrated mealtime insulin analog in the U.S., is now available in pharmacies, Eli Lilly and ...

Humalog (insulin lispro) and Humulin N (insulin isophane human) are brand-name prescription* medications. They’re approved by the Food and Drug Administration (FDA) to help treat type 1 and type 2 ...

--- Positive opinion could lead to first 200 units/ml rapid-acting insulin in Europe for the treatment of type 1 and type 2 diabetes INDIANAPOLIS, July 30, 2014 /PRNewswire/ -- Eli Lilly and Company ...

Please provide your email address to receive an email when new articles are posted on . The European Medicine Agency’s Committee for Medicinal Products for Human Use recommended approval of Eli Lilly ...

--- First 200 units/ml rapid-acting insulin product for the treatment of diabetes INDIANAPOLIS, Oct. 3, 2014 /PRNewswire/ -- Eli Lilly and Company today announced that the European Commission has ...